Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy.

Applications of transdominant mutants of human immunodeficiency virus type 1 (HIV-1) regulatory proteins, especially Rev mutant, have been attempted for gene therapy against AIDS, because the Rev protein is essential for viral replication. We have previously reported that a mutant Rev protein (dRev)...

Descripción completa

Detalles Bibliográficos

Publicado en:	J Virol
Autores principales:	Furuta, R A, Kubota, S, Maki, M, Miyazaki, Y, Hattori, T, Hatanaka, M
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1995
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188754/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7853493/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.69.3.1591-1599.1995
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!